# Survey on the Clinical Use of Recombinant Human Erythropoietin in VLBW and ELBW Infants

> **NCT05372211** · — · UNKNOWN · sponsor: **Shenzhen People's Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Erythropoietin; Infant; Surveys and Questionnaires

## Interventions

- **OTHER:** not use of any intervention

## Key facts

- **NCT ID:** NCT05372211
- **Lead sponsor:** Shenzhen People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05372211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05372211, "Survey on the Clinical Use of Recombinant Human Erythropoietin in VLBW and ELBW Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05372211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*